Morton, John M.

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 1,008

Systematic review on reoperative bariatric surgery

Brethauer, S. A., Kothari, S., Sudan, R., Williams, B., English, W. J., Brengman, M., Kurian, M., Hutter, M., Stegemann, L., Kallies, K., et al. (2014) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 392

Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial

Ikramuddin, S., Blackstone, R. P., Brancatisano, A., Toouli, J., Shah, S. N., Wolfe, B. M., Fujioka, K., Maher, J. W., Swain, J., Que, F. G., et al. (2014) · JAMA

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 214

The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity

The EMPOWER Study Group, Sarr, M. G., Billington, C. J., Brancatisano, R., Brancatisano, A., Toouli, J., Kow, L., Nguyen, N. T., Blackstone, R., Maher, J. W., et al. (2012) · Obesity Surgery

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 162

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Tahrani, A. A., & Morton, J. (2022) · Obesity

Bariatric Surgery and OutcomesObesity, Physical Activity, Diet

Cited by 125

What variables are associated with successful weight loss outcomes for bariatric surgery after 1 year?

Robinson, A. H., Adler, S., Stevens, H. B., Darcy, A. M., Morton, J. M., & Safer, D. L. (2014) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesObesity, Physical Activity, Diet

Cited by 102

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 90